Want to see PCSA full AI Analyst Report?
Processa Pharmaceuticals (PCSA) Q4 2023 Earnings Report
PCSA Q4 2023 EPS Results
- Actual EPS
- -$1.65
- Consensus EPS
- -$1.60
- Beat/Miss
- Missed by -$0.05
- One Year Ago EPS
- -$16.20
PCSA Q4 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/28/2024
- Time
- TBA
- Conference Call
- Thursday, March 28, 2024
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
PCSA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 06, 2026 | 2026 (Q2) | ―-1.19 | -6.25 | 81.01% (+5.06) | |
| Nov 05, 2025 | 2025 (Q3) | -2.00-1.81 | -25.75 | 92.98% (+23.94) | |
| Aug 07, 2025 | 2025 (Q2) | -0.22-0.25 | -1.01 | 75.25% (+0.76) | |
| Mar 27, 2025 | 2024 (Q4) | -0.84-0.77 | -1.7 | 54.71% (+0.93) | |
| Oct 30, 2024 | 2024 (Q3) | -25.00-25.75 | -40 | 35.63% (+14.25) | |
| Aug 28, 2024 | 2024 (Q2) | -25.25-25.25 | -50 | 49.50% (+24.75) | |
| Mar 28, 2024 | 2023 (Q4) | -1.60-1.65 | -16.2 | 89.81% (+14.55) | |
| Nov 08, 2023 | 2023 (Q3) | -0.10-0.08 | -0.37 | 78.38% (+0.29) | |
| Aug 10, 2023 | 2023 (Q2) | -0.15-0.10 | -0.32 | 68.75% (+0.22) | |
| May 11, 2023 | 2023 (Q1) | -0.28-0.18 | -0.2 | 10.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
